Halotech DNA

What Halotech DNA does

Halotech DNA is a private biotechnology company headquartered in Madrid, Spain, focused on the research, development, and marketing of solutions in the field of fertility. Founded in 2008, the company operates with a small team of 11-50 employees and is structured as a for-profit private entity with no disclosed parent organization, subsidiaries, or public listing. The firm identifies its functional domain as fertility biotechnology, indicating it develops and commercializes products or services intended for clinics, laboratories, patients, or other stakeholders involved in human fertility care and reproductive medicine.

The company's underlying technology stack, product catalog, intellectual property portfolio, and distribution model are not documented in the available source material — the company website returned only a verification/loading screen when queried, and no third-party source filled in these gaps. Without confirmed product details, pricing, or partnership information, the revenue mechanics cannot be characterized beyond what the sector context implies: a niche fertility biotech of this size and tenure is most plausibly operating as a specialized product developer, distributor, or service provider within the reproductive medicine supply chain, with sales conducted to clinical or laboratory customers rather than direct-to-consumer.

No public disclosures are available regarding funding rounds, investors, leadership team, geographic markets served, certifications, regulatory clearances, or channel relationships. The company maintains a web presence at halotechdna.com, but substantive first-party content was not accessible at the time of data aggregation. Consequently, while Halotech DNA's basic firmographic identity as a Spanish fertility biotech is established, a deeper assessment of unit economics, competitive positioning, and growth drivers would require primary research beyond what the input data supports.

Name

Halotech DNA

Website

https://halotechdna.com

Company type

Private

Founded year

2008

Headcount range

11–50 employees

Short description

Halotech DNA is a private Madrid-based biotechnology company founded in 2008 that researches, develops, and markets solutions in the field of human fertility, serving clinical and reproductive medicine stakeholders with a small specialized team.

Ownership category

akta.pro rank

Product category

Reproductive Biotechnology / Fertility Diagnostics

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

akta.pro secondary industries

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

Keywords

• Fertility diagnostics
• DNA fragmentation analysis
• Sperm DNA testing
• Reproductive biotechnology
• Andrology solutions

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations

Core offering

Halotech DNA is a biotechnology company that researches, develops, and markets solutions for the fertility field. Its work centers on reproductive health technologies used by fertility professionals and clinics to assess and address fertility-related conditions.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Illumina: Dominant DNA sequencing platform provider whose technology underpins virtually all PGT and reproductive genetic testing. Comparable as a foundational molecular biology / genomics technology provider for the fertility workflow.
• Revvity (formerly PerkinElmer Life Sciences): Large diversified life sciences company with a reproductive health screening business (formerly Vanadis). Comparable in offering molecular/non-invasive reproductive diagnostics within a broader portfolio.
• Labcorp: Major clinical laboratory network offering reproductive and genetic testing services including PGT, carrier screening, and NIPT. Comparable as a downstream clinical channel for reproductive DNA diagnostics.

Direct peers

• Vitrolife: Swedish-listed global leader in IVF media, consumables, and genetic testing (including the acquired Igenomix PGT business). Closely comparable as a full-stack fertility solutions provider with a strong PGT/DNA diagnostics arm.
• Genea Biomedx: Developer of assisted reproductive technology products including time-lapse embryo incubation and IVF lab automation. Comparable as a specialty IVF technology company selling into clinical fertility labs.
• Natera: US-listed genetic testing company with a meaningful reproductive health franchise (Empower, Vistara, Spectrum PGT). Comparable as a DNA-based diagnostics company serving the fertility segment.
• Invitae (acquired by Labcorp): Genetic testing company with a reproductive health portfolio including carrier screening and PGT. Comparable in DNA-based diagnostics and clinical genetics services for the fertility use case.
• CooperSurgical (CooperCompanies): Major provider of fertility and reproductive health products including PGT services, IVF media, and consumables. Comparable in offering breadth across the IVF workflow and clinic relationships.
• Hamilton Thorne: Provider of precision instruments, consumables, and software for the IVF/ART market. Comparable as a smaller, focused supplier of specialized fertility technology with overlapping customer base of IVF clinics.
• Igenomix (Vitrolife): Specialist in preimplantation genetic testing (PGT) and reproductive genetics, now part of Vitrolife. Direct comparable as a molecular diagnostics provider focused specifically on fertility and embryo genetics.

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights4 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/halotech-dna

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Halotech DNA